Glucokinase (GK) encoded by glucokinase gene (GCK) is the first rate-limiting enzyme in glucose metabolism. The heterozygous inactivating mutations of GCK cause maturity-onset diabetes of the young (GCK-MODY). Unlike other types of diabetes, GCK-MODY is not associated with increased risks of diabetic complications in young patients. However, the long-term effects of mutant GK on lipid profiles and chronic complications in elder patients remain unknown. Herein, we established a knock-in mouse model heterozygeously expressing a novel GCK mutation encoding GK-Q26L that was identified in a Chinese family with early onset diabetes. GK-Q26L mice developed mild early onset diabetes with moderate elevated blood glucose and decreased serum insulin, confirming diabetogenes of GK-Q26L. To determine age- and diet-related diabetic complications and lipid profiles, we have fed the mice with either chow diet or high-fat diet (HFD) for 28, 40, or 60 weeks. We found that, after 28 week of HFD, GK-Q26L alleviated abnormal lipid profiles in plasma and liver, suggesting beneficial effects of GK-Q26L on lipid metabolism. Surprisingly however, those protective effects were disappeared at 40 weeks, and at 60 weeks of HFD, GK-Q26L mice exhibited even more severe abnormal lipid profiles. Consistent with the distinct trends of lipid profiles, HFD-induced kidney injury (increased urinary albumin/creatinine ratio and renal fibrosis) was also alleviated in GK-Q26L mice at 28 weeks of HFD, but aggravated at 60 weeks of HFD. Similar effects on diabetic retinopathy were observed in GK-Q26L mice. These data reveal for the first time that although inactivating GCK mutations have beneficial effects on HFD-induced abnormal lipid metabolism and diabetes related damages of kidney and retina in short-term, it is strongly associated with long-term diabetic nephropathy and retinopathy. This study suggests that more attention should be paid on the long-term chronic complications in elder patients with GCK-MODY.

Disclosure

Y.Huang: None. Y.Fan: None. X.Li: None. S.Ji: None. S.Chen: None. J.Cui: None. W.Feng: None. H.Shu: None. M.Liu: None.

Funding

National Natural Science Foundation of China (81830025, 82220108014, 82100865, 81800733, 81900720, 82000796, 82070854); National Key R&D Program of China (2019YFA0802502, 2022YFE0131400); Tianjin Key Medical Discipline Construction Project (TJYXZDXK-030A)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.